PT-141 10MG

Product Overview

PT-141 10MG is a synthetic cyclic melanocortin-receptor agonist research material also known as bremelanotide, supplied as white to off-white lyophilised powder in a 10mg catalogue presentation (SKU P41). This page describes the stated research identity and batch-oriented catalogue specification; it does not provide an administration protocol.

PT-141 research examines melanocortin-receptor pharmacology and centrally mediated physiological or behavioural endpoints. The literature includes receptor studies and controlled clinical development.

Identity and Specifications

• Product: PT-141 10MG
• SKU: P41
• Format: White to off-white lyophilised powder
• Synonyms: Bremelanotide, PT-141
• Catalogue purity specification: ≥99%
• CAS number: 189691-06-3
• Molecular formula: C50H68N14O10
• Molecular weight: 1025.2 g/mol
• Amount: 10mg

Research Context

The following themes summarise published research on the named molecule or components. They are research contexts, not claims about the supplied ExtolX batch.

Areas of Research

• melanocortin-receptor activation and selectivity
• central neural signalling
• cyclic-peptide pharmacology
• controlled clinical-study methodology

Evidence Quality and Limitations

Clinical findings concern regulated study formulations and protocols. They do not validate this independent lyophilised vial or justify administration.

Storage and Handling

Before reconstitution: Keep the lyophilised vial sealed, dry and protected from light at −20°C or below, subject to the batch-specific supplier documentation. Published bremelanotide and bremelanotide-acetate reference data support frozen storage, but the counter-ion and formulation of this ExtolX batch have not been confirmed. Allow a cold vial to reach room temperature before opening to reduce condensation.

After reconstitution: Stability depends on the exact salt or formulation, solvent, concentration, pH and container. Prepare only what the validated method requires. If that method supports frozen storage, use single-use aliquots and avoid repeated freeze–thaw cycles. Use clean laboratory technique, avoid vigorous agitation, and record the preparation and storage history. No numerical solution shelf life has been verified for this ExtolX batch.

Compatibility Limitations

Do not infer solubility or stability from another peptide, blend, amount or pharmaceutical formulation. Use small-scale method development and appropriate analytical controls before committing valuable material.

Laboratory Safety

Handle only in an appropriately equipped laboratory by trained personnel. Use a task-specific risk assessment, suitable personal protective equipment and applicable safety documentation. Avoid ingestion, inhalation, skin contact and environmental release, and dispose of waste in accordance with local requirements.

Sources

• MedChemExpress storage references: Bremelanotide and bremelanotide acetate
• PubMed: PT-141 melanocortin research
• PubMed: Neurobiology of bremelanotide
• PubMed: Clinical pharmacology of PT-141
• PubMed: Phase 3 bremelanotide studies
• PubMed: Melanocortins in sexual-response research

Scientific sources last reviewed: 23 August 2026.

Research Use Agreement & Disclaimer

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.